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Abstract: Clitoria ternatea (commonly known as blue pea) flower petal extract (CTE) is used as a natural
colorant in a variety of foods and beverages. The objective of study was to determine the inhibitory
effect of CTE on adipogenesis in 3T3-L1 preadipocytes. The phytochemical profiles of CTE were
analyzed by liquid chromatography and tandem mass spectrometry (LC-MS/MS). Anti-adipogenesis
effect of CTE was measured by using Oil Red O staining, intracellular triglyceride assay, quantitative
real-time PCR and western blot analysis in 3T3-L1 adipocytes. Cell cycle studies were performed
by flow cytometry. Lipolysis experiments were performed using a colorimetric assay kit. In early
stages, CTE demonstrated anti-adipogenic effects through inhibition of proliferation and cell cycle
retardation by suppressing expression of phospho-Akt and phospho-ERK1/2 signaling pathway.
The results also showed that CTE inhibited the late stage of differentiation through diminishing
expression of adipogenic transcription factors including PPARγ and C/EBPα. The inhibitory action
was subsequently attenuated in downregulation of fatty acid synthase and acetyl-CoA carboxylase,
causing the reduction of TG accumulation. In addition, CTE also enhanced catecholamine-induced
lipolysis in adipocytes. These results suggest that CTE effectively attenuates adipogenesis by
controlling cell cycle progression and downregulating adipogenic gene expression.
Keywords: Clitoria ternatea extract; adipogenesis; lipolysis; inhibition; adipocytes
1. Introduction
Obesity is one of leading factors in the metabolic syndrome caused by an imbalance between
food intake and energy expenditure [1,2]. Nowadays, obesity is a growing global health problem,
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responsible for the development of type 2 diabetes, cardiovascular diseases and atherosclerosis [3–5].
Obesity is mainly associated with increased expansion of white adipose tissue through the activation
of adipogenesis [5]. The process of adipogenesis involves the changes of cell morphology from
fibroblast-like shape of preadipocytes to mature and increased lipid synthesis and accumulation in
adipocytes. Adipogenesis is generally described as a two-step process including cell proliferation and
differentiation, resulting in an increase of the number (hyperplasia) and size (hypertrophy) of adipocytes.
In early stage, pre-adipocytes are proliferated through activation of Akt and ERK signaling pathway.
After the proliferative phase, they undergo to the formation of mature adipocytes from fibroblast-like
pre-adipocyte into spherical shape. Accumulation of the triglyceride (TG) in mature adipocyte is
activated by expression of adipogenic transcriptional factors including PPARγ and C/EBPα leading to
regulation of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) [6]. Moreover, Akt1 and
MAPK signaling pathway plays a pivotal role in regulating adipogenesis from cell proliferation to
differentiation [7–9]. Activation of Akt1 contributes to promote cell cycle progression and terminal
differentiation into mature adipocyte [10]. It has shown that activation of Akt1 markedly inhibited
p21 and p27 (Cdk inhibitors) and subsequently triggered Cdk2 in the cell cycle progression [10,11].
As a result, mature adipocytes expand in size through the increased storage of triglycerides [10].
Besides, these can be hydrolyzed by hormone sensitive lipase (HSL) under deprivation status for
energy homeostasis in response to catecholamines and insulin [12]. Apart from the Akt pathway,
the ERK signaling pathway also contributes to the commitment effect in adipogenesis by initiating the
proliferative step and increasing differentiation in adipocytes [13,14].
To date, there has been considerable interest in studying the effect of dietary plants on the prevention
of obesity because they are largely free from side effects [15–17]. Clitoria ternatea L. (family: Fabaceae) or
butterfly pea is widely distributed in tropical countries, South and Central America. This plant has been
used for centuries in foods and medicines. In Asia and America, it is traditionally recommended for the
treatment of snakebites, scorpion stings, chronic bronchitis, indigestion, constipation, fever, arthritis,
eye ailments, sore throats, skin diseases, rheumatism, syphilis, eye and ear-diseases [18]. The flower
petals of C. ternatea, which contain abundant anthocyanin pigments have considerable potential for
application as a source of natural colorants in a variety of foods and beverages. The phytochemical
components of C. ternatea flower extract (CTE) are mainly delphinidin-derived anthocyanins, including
delphinidin-3,5-glucoside, delphinidin-3-glucoside and six major delphinidin-based ternatins (ternatins
A1, A2, B1, B2, D1 and D2) [19,20]. CTE has been reported to possess various pharmacological
effects such as antioxidant, antiglycation, antimicrobial, anti-platelet aggregation, anti-inflammatory,
antipyretic, and antihelmintic activity [18,21,22]. In addition, CTE exerts antihyperglycemic and
antihyperlipidemic effects in alloxan-induced diabetic rats [23,24]. Recently, CTE has shown
anti-glycation activity through inhibition of formation of AGEs in fructose-glycated bovine serum
albumin (BSA) [21]. It also prevents oxidative damage to BSA due to its free radical scavenging
ability [21]. Although the antidiabetic and antiglycation activity of CTE has been well documented,
studies regarding the effect of CTE on adipogenesis remain unknown. Therefore, the objective of
current study was to elucidate the inhibitory effect of CTE and its underlying cellular mechanisms on
adipogenesis and lipid accumulation by using 3T3-L1 cells.
2. Results
2.1. Characterization and Identification of Phenolic Compounds in CTE by LC-MS/MS
From the chromatograms obtained by LC/MS/MS (Figure 1), 14 compounds were identified
based on their retention times, high-resolution mass spectral data (MS and MS/MS) of the
fragment ions, and comparisons with previously published literature [25,26]. As reported
in Table 1, the compounds were identified as preternatin A3, ternatin B2, ternatin D2,
quercetin-3-rutinoside, ternatin D1, kaemferol-3-O-(2-rhamnosyl) rutinoside, delphinidin-3-glucoside,
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kaemferol-3-O-rutinoside, delphinidin-3-O-(6-O-p-coumaryl)glucoside-pyruvic acid, (+)-catechin
7-O-β-glucoside, syringetin-3-O-glucoside, quercetin triglycoside, and delphinidin derivatives (Figure 2).Molecules 2019, 24, x FOR PEER REVIEW 3 of 16 
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Figure 1. LC-MS/MS chromatogram of the Clitoria ternatea flower extract (CTE). (A) The expanded
range of CTE chromatogram during 0–18 min. (B) The profile of CTE chromatogram (the number
indicates isolated compounds).
Table 1. Chromatographic MS and MS/MS data and the chemical structure of identified compounds
in CTE.
No. Rt (min) Compound Product Ion
1 11.098 Preternatin A3
1405.3310 [M + H]+, Calcd Mass: 1405.3876,
MS/MS: 1329.2817, 1183.2193, 1021.2119, 876.1811,
739.1818, 627.1281, 493.3180, 471.3372
2 11.826 Delphinidin derivatives
788.4017 [M + H]+, Calcd Mass: 789.2084,
MS/MS: 801.3825 [M + Na]+, [Quercetin
3-glucoside+dihexose]
3 12.277 Ternatin B2
1637.3591 [M + H]+, Calcd Mass: 1637.4248,
MS/MS: 1389.3186, 757.1914, 611.1385, 465.0866,
303.0396
4 12.797 Ternatin D2 1475.3163 [M + H]
+, Calcd Mass: 1475.3720,
MS/MS: 741.1967, 595.1441, 449.0916, 287.0456
5 13.040 Quercetin-3-rutinoside (rutin) 611.1384 [M + H]
+, Calcd Mass: 610.1534,
MS/MS: 465.0860, 303.0399
6 13.109 Ternatin D1
1697.3959 [M + H − Malonyl]+, Calcd Mass:
1697.4612, MS/MS: 1389.3165, 1243.2461, 611.1379,
465.0855, 303.0396
7 13.664 Kaemferol-3-O-(2-rhamnosyl)rutinoside
741.1969 [M + H]+, Calcd Mass: 740.2164,
MS/MS: 595.1443, 449.0924, 287.0457
8 14.080 Delphinidin-3-glucoside(myrtillin)
465.0856 [M + H]+, Calcd Mass: 465.1028,
MS/MS: 487.0665 [M + Na]+, 303.0390
9 14.218 Kaemferol-3-O-rutinoside 595.1437 [M + H]
+, Calcd Mass: 94.1585,
MS/MS: 588.3886, 566.4074, 449.0917, 287.0454
10 14.738 Delphinidin-3-O-(6-O-p-coumaryl)glucoside-pyruvic acid
679.4869 [M + H]+, Calcd Mass: 679.1294,
MS/MS: 701.4680 [M + Na]+, 595.1422, 340.2488
11 15.4311 (+)-Catechin 7-O-β-glucoside
453.3275 [M + H]+, Calcd Mass: 452.1319,
MS/MS: 927.6276 [2M + Na]+, 905.6462 [2M +
H]+, 814.5468
12 15.639 Syringetin-3-O-glucoside 509.8675 [M + H]
+, Calcd Mass: 508.1217,
MS/MS: 1040.7075 [2M + Na]+
13 16.402 Quercetin triglycoside 759.3755 [M + H]
+, Calcd Mass: 758.1906,
MS/MS: 781.3571 [M + Na]+
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2.2. Effects of CTE on Cell Viability of 3T3-L1 Cells
To deter i e hether CTE has cytotoxicity to 3T3-L1 cells, various concentrations of CTE
(500–2000 µg/mL) were incubated with 3T3-L1 cells during adipogenesis process. There was no toxicity
of CTE to 3T3-L1 cells at the concen ration up to 2000 µg/mL at day 1, 3 and 9 (before and after
differentiation) (Figure 3 – .
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Figure 3. Effects c ll viability of 3T3-L1 cells by trypan blue assay at day 1 (A), day 3 (B) and
day 9 (C). Each value represent the m an ± SEM (n = 3).
2.3. Effects of CTE on the Cell Cycle of 3T3-L1 Cells
As shown in Figure 4A–D, the results showed that CTE at concentration of 250, 500 and 750
µg/mL significantly delayed the cell cycle by increasing the cell distribution in G0/G1 phase from
control at 34.23 ± 2.01% to 44.88 ± 1.07%, 48.66 ± 1.23% and 52.26 ± 2.62%, respectively. In addition,
CTE concentration-dependently decreased of G2/M phase from control at 46.26 ± 5.29 to 43.07 ± 0.64,
41.12 ± 1.13 and 38.83 ± 0.46%, respectively.
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Figure 4. Effects of CTE on cell cycle of 3T3-L1 cells at day 1. Histograms are shown as the control
group (A), CTE 250 µg/mL (B), 500 µg/mL (C), 750 µg/mL (D). Each value represents the mean ± SEM
(n = 3).
2.4. Effects of CTE on Akt1 and ERK1/2 Signaling Pathways in 3T3-L1 Cells
The results demonstrated the CTE at concentrations of 500, 750 and 1000 µg/mL significantly
reduced the phosphorylation level of Akt1 (T308), which ranged from 45.16 ± 1.37% to 91.95 ± 0.31%,
as compared to the control (Figure 5A). Furthermore, CTE at concentration of 750 and 1000 µg/mL
also significantly suppressed the phosphorylation of ERK1/2 (T202/Y204) about 62.15% and 94.04%,
respectively (Figure 5B). However, CTE (500 µg/mL) did not significantly alter the phosphorylation
level of ERK1/2.
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Figure 5. Effects of CTE on Akt (A) and ERK (B) pathway of 3T3-L1 cells at day 9. The relative values
of P (phospho)-Akt1 (T308) to T (total)-Akt1 and P-ERK1/2 (T204/Y202) to T-ERK are shown in % of
control. Each value represents the mean ± SEM (n = 3). a p < 0.05 compared with the control group.
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2.5. Effects of CTE on Lipid Accumulation in 3T3-L1 Cells
After cells were exposed to the inducer including dexamethasone, insulin, and IBMX, 3T3-L1 cells
were differentiated to mature adipocytes, as characterized by triglyceride-rich lipid droplet structure
histologically. The result demonstrated that CTE (500–1000 µg/mL) significantly decreased Oil-red
O staining lipid droplet (26.40 ± 2.14%, 52.86 ± 2.33% and 68.25 ± 2.78%) when compared to control
(Figure 6A–D). Furthermore, the accumulation of triglyceride was significantly lowered when the cells
was incubated with CTE at the concentration of 500, 750 and 1000 µg/mL (59.05–74.30%), as shown in
Figure 6E. The effects of CTE on lipolysis in 3T3-L1 cells is shown in Figure 6F. After 3T3-L1 cells were
turned into mature adipocytes, they were exposed to various concentrations of CTE (500–1000 µg/mL)
for 1 h. CTE (500–1000 µg/mL) significantly increased lipolysis in a concentration-dependent manner
(27.90–57.88%).
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magnification). The quantification of lipid content is shown in % of control (D). Triglyceride content 
is shown in nmol/mg protein (E). Lipolysis is shown as glycerol release in nmol/mg protein/h (F). 
Each value represents the mean ± SEM (n = 3). a p < 0.05 compared with the control group. 
  
 
CTE(μg/mL)
CTE(μg/mL)CTE(μg/mL)
(D) (E)
Figure 6. Effects of CTE on lipid accumulation and lipolysis of 3T3-L1 cells at day 9. Undifferentiated
cells (A), differentiated cells (B) and 1000 µg/mL CTE (C) were stained by Oil red O (40× magnification).
The quantification of lipid content is shown in % of control (D). Triglyceride content is shown in
nmol/mg protein (E). Lipolysis is shown as glycerol release in nmol/mg protein/h (F). Each value
represents the mean ± SEM (n = 3). a p < 0.05 compared with the control group.
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2.6. Effects of CTE on Adipogenic Transcription Factors and Lipogenic Enzymes
In respect to Figure 7A,B, CTE (500–1000 µg/mL) significantly suppressed mRNA expression of
PPARγ (38.33 ± 3.96%–59.83 ± 2.50%) and C/EBPα (21.49 ± 2.22%–58.94 ± 1.74%).
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Each value represents the mean ± SEM (n = 3). a p < 0.05 compared with the control group.
Figure 8A demonstrates the protein expression of adipogenic transcription factors and lipogenic
enzymes in 3T3-L1 cells. As shown in Figure 8B,C, CTE (500–1000 µg/mL) reduced the protein level
of PPARγ (53.50 ± 5.71%–99.99 ± 0.01% and C/EBPα (34.36 ± 1.78%–62.16 ± 1.43%). As illustrated in
Figure 8D,E, CTE (750–1000 µg/mL) significantly decreased the level of FAS whereas 500–1000 µg/mL
could reduce the protein expression of ACC.
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3. Discussion
It has been demonstrated that the inhibition of adipogenesis involves the reduction in both number
and lipid content of adipocytes [27]. Suppressing differentiation and proliferation, and lipogenesis
as well as stimulatory lipolysis are the strategies for prevention and treatment of obesity [17].
It has been reported that medicinal plants and their bioactive compounds possess anti-obesity
activity [28]. For example, blueberry peel, citrus aurantium and curcumin extracts inhibit adipogenesis
through down-regulation of PPARγ and C/EBPα, resulting in decreased cell number and lipid
accumulation of adipocytes [29,30]. Recent findings indicated that the blockage of cell cycle through
inhibition of Akt1 and ERK1/2 signaling pathway effectively prevents cell proliferation, expression of
adipogenic transcription factors, and lipid accumulation in adipocytes [7,14,29,31]. Our current results
demonstrated that CTE inhibited the early stage of adipogenesis in 3T3-L1 cells through the suppression
of Akt1 and ERK1/2 signaling pathways. Inhibition of this pathway might result in the reduction of
hyperplasia in adipocytes [32]. In addition, CTE increased cell cycle arrest by inversion of cell cycle
from G2/M to G0/G1 phase. This effect was linked to the suppression of phosphorylated Akt1 at T308
and ERK1/2 at T202/Y204. Many studies have been reported that the phosphorylation of Akt (T308 or
ser473) and ERK1/2 (T202/Y204) at the active sites is required for stimulating adipogenesis [13,33–35].
For instance, Coptis chinensis extract exerts anti-adipogeneic effects via reduction of phosphorylation
of ERK1/2 (T202/Y204) and Akt1 (T308) during adipogenesis which was consistent with the current
studies [36]. Moreover, kaempferol delayed cell cycle progression by blocking the phosphorylation
of Akt [37]. After cells were exposed to the adipogenic inducers including IBMX, insulin and
dexamethasone at the late stage, 3T3-L1 cells differentiated to mature adipocytes, resulting in the lipid
accumulation. Our findings were consistent with previous studies [37]. In the present study, increased
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expression of transcription factors including PPARγ and C/EBPα was observed at both mRNA and
protein levels. The activation of PPARγ and C/EBPα directly regulates the expression of FAS and
ACC leading to conversion of acetyl-CoA to malonyl-CoA and then malonyl-CoA to saturated fatty
acids driving formation of triglyceride [38]. Furthermore, the accumulation of triglyceride increases
the size of adipocytes [6]. There are several studies reporting that suppressing mRNA or protein
expression of FAS markedly prevents the accumulation of triglyceride in adipocytes [29,30,39,40].
For example, cocoa tea water extract inhibits lipogenesis by suppressing expression of lipogenic
transcription factors and their target genes such as PPARγ, C/EBPα, FAS, and ACC leading to reduced
accumulation of triglyceride in 3T3-L1 cells [41]. Our results showed that CTE dramatically inhibited
the late stage of adipogenesis through the inhibition of triglyceride accumulation and expression of
adipocyte-associated transcriptional factors and enzymes including PPARγ, C/EBPα, FAS and ACC.
Moreover, lipolysis is generally induced by hormone-sensitive lipase (HSL) and consequently released
free fatty acid and glycerol and decreased the cell size of adipocytes [42]. It has been reported that
black soybean enriched anthocyanin could increase the lipolysis of 3T3-L1 cells, thereby, reduction
of cell mass and size [43]. Additionally, polyphenol rich-white tea extract exerts the inhibitory effect
on adipogenesis through an increased lipolysis concomitant with suppression of adipogenic markers
including SREBP-1c and PPARγ [44]. Suppression of phosphorylated Akt could stimulate HSL in
3T3-L1 cells [45]. The current findings indicated that CTE enhanced lipolysis related to activation of
hormone sensitive lipase in adipocytes. The results from this effect cause a decrease in TG accumulation
in adipocytes.
Previous studies have demonstrated that CTE contains delphinidin-3,5-glucoside,
delphinidin-3-glucoside, malvidin-3-glucoside, kaempferol, quercetin-3-O-(2-rhamnosyl) rutinoside, rutin,
and six major delphinidin-based ternatins (ternatins A1–A3, B1–B4, C1–C5 and D1–D3) [19,25,26,46].
In the similar pattern, the major bioactive compounds in CTE are on the basis of flavanol glycosides
and delphinidin derivatives in this study. It has been clearly shown that several phytochemical
compounds exert the inhibitory effect on adipogenesis [27]. For instance, dietary flavonoids including
kaempferol, quercetin and myricetin suppressed the adipogenesis by inactivation of Akt1 pathway
leading to inhibiting of cell cycle progression, lipid accumulation and transcriptional factor expression
in 3T3-L1 cells and human adipose tissue-derived mesenchymal stem cells [36,47]. Rutin could
suppress the adipocyte differentiation in 3T3-L1 cells by down-regulating of PPARγ and C/EBPα [48].
As aforementioned, CTE exerts inhibitory effects on adipogenesis by attenuating proliferation of cell,
progression of cell cycle (Akt and MAPK), expression of adipogenic transcription factors (PPARγ and
C/EBPα) and lipogenic enzymes (FAS and ACC) and enhancing lipolysis. The probable mechanism by
which CTE exerts anti-adipogenesis may be associated with the identified phytochemical compounds
in the extract. Further studies should be done to prove its anti-obesity effect in animal models.
In summary, CTE inhibits cell cycle and adipogenesis at both early and late stages through Akt and
MAPK signaling pathway. In late stage, CTE reduces lipid accumulation and the expression of
adipogenic transcription factors and enzymes together with enhancement of lipolysis in adipocytes.
CTE could be a natural food for prevention of adipogenesis and enhancement of lipolysis.
4. Materials and Methods
4.1. Chemicals
3T3-L1 preadipocytes were purchased from American Type Culture Collection (ATCC, Manassas,
VA, USA). Dulbecco’s modified Eagle’s medium (DMEM) and penicillin-streptomycin were purchased
from Mediatech (Herndon, VA, USA). Oil red O solution, isobutylethylxanthine (IBMX), dexamethasone,
and insulin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies including
phospho (P)-Akt1 (T308), total (T)-Akt1, P-ERK1/2 (T202/Y204), T-ERK1/2, C/EBPα, PPARγ, Fatty acid
synthase (FAS), Acetyl-CoA carboxylase (ACC) and GAPDH were purchased from Cell Signaling
Technology (Boston, MA, USA).
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4.2. Plant Materials
Dried flowers of C. ternatea were purchased from a local herbal shop in Bangkok, Thailand.
The plant was authenticated at the Division of Plant Varieties Protection, Department of Agriculture,
Ministry of Agriculture and Cooperatives, Bangkok, Thailand. A specimen was deposited at the
institute herbarium under code no: BK066793. The extraction of the plant followed a previously
published method [21]. Briefly, the dried plant was extracted with distilled water at 95 ◦C for 2 h.
The sample was then filtered through Whatman 70 mm filter paper. The aqueous solution was dried
using a spray dryer SD-100 (Eyela world, Tokyo Rikakikai Co., Ltd., Tokyo, Japan). The spray drying
conditions were: inlet temperature (178 ◦C), outlet temperature (80 ◦C), blower (0.9 m3/min) and
atomizing pressure (90 kPa). Total phenolic, flavonoid, and anthocyanin content were 53 ± 0.34 mg
gallic acid equivalents/g dried extract, 11.2 ± 0.33 mg catechin equivalents/g dried extract, and 1.46 ±
0.04 mg cyanidin-3-glucoside equivalents/g dried extract, respectively [21].
4.3. Sample Preparation for LC-MS/MS
Anthocyanin fractions were obtained using an activated Oasis HLB cartridge (Waters Corp.,
Milford, MA, USA), according to the modified procedure of previous study with minor modification [49].
Briefly, the dried CTE was resolubilized in distilled water and applied to an activated Oasis HLB
cartridge. The cartridge was washed with 0.01% hydrochloric acid in water, followed by ethyl acetate
and then 0.01% hydrochloric acid in methanol to elute anthocyanins. Then, the eluent was dried
with nitrogen gas and used for LC-MS/MS analysis. The purified CTE was resolubilized with 0.5%
formic acid solution to give a final concentration of 1 mg/mL and filtered through a 0.45 µm pore size
poly-(tetrafluoroethylene) (PTFE) membrane syringe filter (Corning, New York, NY, USA) prior to
injection into the LCMS/MS for identification and quantification of anthocyanins.
4.4. Characterization of CTE
The phytochemical compound in the enriched extract were directly analyzed by liquid
chromatography and tandem mass spectrometry (LC-MS/MS) according to the conditions previously
described by a previous study [25]. LC-MS/MS was performed using a Quadrupole/Time-Of-Flight
Mass Spectrometer (QTOF LC-MS/MS; Model-6540 UHD Agilent Technologies, Santa Clara, CA,
USA) using a Dual ESI ion source attached to an Agilent 1260 series liquid chromatograph.
A 150 × 4.6 mm, particle size 5 µm C18 reversed phase column (VertiSep™ AQS—Vertical
Chromatography Co., Ltd., Nonthaburi, Thailand) was used at a flow rate of 0.5 mL/min and
40 min of the total run time. The HPLC gradients were consisted of eluent A; 0.1% formic acid in water
and eluent B 0.1% formic acid in acetonitrile. The system was run with the following gradient program:
0 min: 95% of linear gradient until 5% of A in 40 min and post run for 5 min. The mass spectral data
were acquired with the following ESI inlet conditions: the scanning mass-to-charge (m/z) ranging from
100 to 1700 with a scan rate of 4.00 spectra s−1, the capillary voltage of 3500 V (positive mode) and the
fragmentor of 100 V. The pressure of the nebulizer was set at 30 psi, the drying gas temperature at 350
◦C, and the continuous gas flow to 10 L min−1.
4.5. Culture and Differentiation of 3T3-L1 Cells
3T3-L1 cells were cultured and differentiated as described in the ATCC’s instructions [50]. Briefly,
cells were grown in DMEM containing 10% fetal bovine serum, 2 mM l-glutamine, 100 IU/mL penicillin,
and 100 µg/mL streptomycin. After cells reached 100% confluence, they were grown in the DMEM
supplemented with 10µg/mL insulin, 0.5 mM IBMX, and 1µM dexamethasone (differentiation medium)
for 5 days. At day 5 until day 9, cells were then grown in DMEM supplemented with only 10 µg/mL
insulin (post-differentiation media).
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4.6. Cell Viability Assay
The cell viability of 3T3-L1 cells was also analyzed using a trypan blue assay as reported in a
previous study [51] with minor modifications. 3T3-L1 cells (1 × 104 cells/mL) were incubated with
CTE (125–2000 µg/mL) for 1, 3 and 9 day. The trypsinized cell suspension were immediately stained
with 0.4% trypan blue for 3 min. The viable cells were counted by automated cell counter (BioRad,
Hercules, CA, USA). The viability was expressed as the percentage ratio of the number of unstained
cells relative to the total cells counted.
4.7. Oil Red O Assay
Oil red O assay was performed according to a previously described method with slight
modifications [50]. In brief, 3T3-L1 cells were incubated with CTE (500–1000 µg/mL) until day
9 and differentiated mature adipocytes were then fixed by 10% formaldehyde. After the cells were
stained with 60% oil red O solution for 10 min, the cells were washed twice with phosphate buffered
saline (PBS). Finally, the cells were incubated with 100% isopropanol at 37 ◦C for 10 min. The absorbance
was measured at 540 nm.
4.8. Cell Cycle by Flow Cytometry
Cell cycle analysis was performed following a previously published report with slight
modifications [51]. After 3T3-L1 cells were incubated with CTE (125–500 µg/mL) for 24 h, cells were
trypsinized and fixed with 50% ethanol at 4 ◦C for 2 h. Cells were then washed and re-suspended in
PBS containing 200 µg/mL RNase A and 50 µg/mL propidium iodide for 30 min at room temperature.
DNA content was measured by flow cytometry (FC550, Beckman Coulter, Brea, CA, USA) and analyzed
using the Flowjo software. Cells at least 1 × 104 counts were made for each sample.
4.9. Western Blot Analysis
Western blot analysis was performed following a previously described method [52]. To determine
the protein signaling from proliferation stage such as Akt1 and ERK1/2, the protein was extracted
after the incubation with growth media without differentiation cocktail. In addition, the protein
extraction of 3T3-L1 cells exposed to differentiation media for 9 days was performed to determine the
protein signaling differentiation process including PPARγ, C/EBPα, FAS and ACC. Cells were lysed
with ice-cold RIPA buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1% nonionic detergent (NP40),
0.1% sodium dodecyl sulfate (SDS) and 0.5% sodium deoxycholate) containing protease inhibitor (2 mM
PMSF) and phosphatase inhibitor (100 mM NaF, 1 mM Na3VO4). After centrifugation, the protein
content was quantitated by using pierce® BCA protein assay kit Thermo Scientific, Rockford, IL, USA).
The lysate was resolved by SDS-PAGE and transferred to nitrocellulose membrane. The membrane
was then blocked and probed for specific markers by specific primary antibody. After incubation
with horseradish peroxidase-conjugated secondary antibody, membrane-bound target protein was
developed and detected using chemiluminescent system (Thermo Scientific). The intensity of each
band was quantified by using image J software. Relative expression levels of Akt1 and ERK1/2 were
depicted as a ratio of P-Akt1 (T308) to T-Akt1 and P-ERK1/2 (T202/Y204) to T-ERK1/2, respectively.
Relative expression levels of PPARγ, C/EBPα, FAS and ACC proteins were shown in ratio of PPARγ,
C/EBPα, FAS and ACC to GAPDH, respectively.
4.10. Triglyceride Accumulation
Triglyceride content was measured by a colorimetric/fluorometric assay kit (Biovision, Milpitas,
CA, USA) according to manufacturer’s instruction. Briefly, 3T3-L1 cells were seeded into 96-well
plate with differentiation process with CTE (500–1000 µg/mL) until they became mature adipocytes.
Thereafter, lipid droplets were extracted by the extraction buffer and triglyceride was then converted
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to glycerol and fatty acid by using lipase enzyme. The released glycerol was measured at wavelength
of 570 nm.
4.11. Lipolysis Assay
Lipolysis assay was performed following the manufacturer’s instructions of a lipolysis colorimetric
assay kit (Biovision). Briefly, 3T3-L1 cells were seeded into 96-well plate with differentiation process
until they turned into mature adipocytes. The cells were then exposed to the CTE (500–1000 µg/mL) at
37 ◦C for 1 h. Lipolysis was induced by adding synthetic catecholamine into the cultures that activate
β-adrenergic receptor and catalyzes the alteration of ATP to cAMP. The activation of hormone-sensitive
lipase hydrolyzed triglyceride to glycerol and fatty acids. Glycerol released from 3T3-L1 cells was
measured at wavelength of 570 nm. The result was shown as nmol glycerol/mg protein.
4.12. Real-time PCR
After treatment of 3T3-L1 cells with CTE, RNA was extracted from 3T3-L1 cells by using RNeasy
Plus Mini Kit (Qiagen, Foster City, CA, USA) and cDNA library was synthesized by using an iScript
cDNA synthesis kit (BioRad) according to manufacturer’s suggestions. Reverse transcription was
performed with 200 ng of total RNA sample, 1× iScript reaction mix and 1XiScript reverse transcriptase.
Quantitative analysis of cDNA was performed using CFX96 TouchTM real time PCR detection system
(BioRad) and SsoAdvancedTM universal probes supermix (BioRad) according to the manufacturer’s
instructions. Briefly, amplification of the target cDNA was carried out with each 10 µL PCR mixtures
containing 1 µL cDNA, 5 µL SSO probes, 0.5 µL primers and 3.5 µL nuclease free water. Target cDNA
was amplified by using verified commercially available primer pairs (Mm01205647_g1 for Beta-actin,
Mm01331626_m1 for Akt1, Mm00440940_m1 for PPARγ and Mm00514283_s1 for C/EBPα, Thermo
Fisher Scientific, Pleasanton, CA, USA). The conditions of PCR reaction were set as follows: it was
begun by denaturation cycle at 95 ◦C for 30 min, followed by 95 ◦C 10 min and 60 ◦C for 25 min,
respectively. The mRNA expression was normalized with beta-actin following by using 2−∆∆CT
method. Relative gene expression was expressed as fold change in mRNA expression level compared
with control.
4.13. Statistical Analysis
Data were expressed as mean ± standard error of mean (SEM), n = 3. The statistical significance
was evaluated by one-way ANOVA and Tukey’s HSD test (PASW Statistics 18, SPSS Inc., Chicago, IL,
USA). p < 0.05 was considered to be statistically significant.
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